Lieberman, Ph.D. and lab identified and tested a new method for targeting certain cancers caused by Epstein-Barr Virus (EBV), in the paper, "USP7 inhibitors destabilize EBNA1 and suppress EBV ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback